Laura Montejano

Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation

Bruno Paiva, María‐Belén Vídriales, Jorge Cerveró et al. · Blood · 2008 · 475 citations · Full text

Medicine, Hematology, Immunology +17

Prognostic Value of Immunophenotyping in Multiple Myeloma: A Study by the PETHEMA/GEM Cooperative Study Groups on Patients Uniformly Treated With High-Dose Therapy

Gema Mateo, María-Ángeles Montalbán, María‐Belén Vídriales et al. · Journal of Clinical Oncology · 2008 · 210 citations · Full text

Medicine, Hematology, Oncology +16

Genetic Abnormalities and Patterns of Antigenic Expression in Multiple Myeloma

Gema Mateo, Mariana Castellanos, Ana Rasillo et al. · Clinical Cancer Research · 2005 · 125 citations · Full text

Life Sciences, Genetics, Hematology +17

The persistence of immunophenotypically normal residual bone marrow plasma cells at diagnosis identifies a good prognostic subgroup of symptomatic multiple myeloma patients

Bruno Paiva, María‐Belén Vídriales, Gema Mateo et al. · Blood · 2009 · 75 citations · Full text

Medicine, Hematology, Pathology +15

Evaluation of minimal residual disease in multiple myeloma patients by fluorescent‐polymerase chain reaction: the prognostic impact of achieving molecular response

Pilar Martínez‐Sánchez, Laura Montejano, María Eugenia Sarasquete et al. · British Journal of Haematology · 2008 · 58 citations

Medicine, Hematology, Oncology +17